Dong Yongqi, Cao Haiyan, Xu Hongyan, Zhang Zhihuan, Zhou Zhihang, He Song
Department of Gastroenterology, Wushan County People's Hospital of Chongqing, No.168, Guangdongxi Road, Wushan County, Chongqing, 404700People's Republic of China.
Department of Gastroenterology, Chengdu Second People's Hospital, NO.10, Yunnan Road, Chengdu, 610017, People's Republic of China.
Heliyon. 2024 Sep 10;10(19):e37731. doi: 10.1016/j.heliyon.2024.e37731. eCollection 2024 Oct 15.
Esophagogastric variceal bleeding (EVB) is one of the main causes of cirrhosis-related deaths, and endoscopic therapy is the first-line treatment of choice. However, the efficacy of prophylactic endotracheal intubation (PEI) before endoscopy remains controversial.
Data were collected from 119 patients who underwent endoscopic confirmation of an EVB. Inverse probability of treatment weighting was applied to reduce bias between the two groups. The primary outcomes included rebleeding rates within 24 h and 6 weeks post-endoscopic surgery and 6-week mortality.
After endoscopic surgery, the rebleeding rate within 24 h in the PEI group was significantly lower than non-PEI group (1.2 % VS 12.6 %, P-value = 0.025). Although PEI did not reduce 6-week mortality, it significantly reduced the risk of rebleeding within 24 h (odds ratio [OR]: 0.89, 95 % confidence interval [CI]: 0.82-0.97, P = 0.008) and within 6 weeks (hazard ratio [HR]: 0.36, 95%CI: 0.14-0.90, P = 0.029). In multivariate regression analyses, maximum varices diameter >1.5 cm (OR: 1.23, 95 % CI: 1.09-1.37, P < 0.001) was independent risk factor for rebleeding within 24 h. Creatinine (HR: 1.01, 95 % CI: 1.01-1.02, P < 0.001) and international normalized ratio (HR: 2.99, 95 % CI: 1.99-4.65, P < 0.001) were independent risk factors for rebleeding within 6 weeks.
PEI before endoscopic surgery reduced the incidence of rebleeding within 24 h and 6 weeks after endoscopic surgery. However, PEI did not reduce the 6-week mortality rate after endoscopic surgery and might increase the length of hospital stay.
食管胃静脉曲张出血(EVB)是肝硬化相关死亡的主要原因之一,内镜治疗是一线首选治疗方法。然而,内镜检查前预防性气管插管(PEI)的疗效仍存在争议。
收集119例行内镜确诊为EVB患者的数据。采用治疗权重逆概率法以减少两组之间的偏差。主要结局包括内镜手术后24小时内及6周内的再出血率和6周死亡率。
内镜手术后,PEI组24小时内的再出血率显著低于非PEI组(1.2%对12.6%,P值=0.025)。虽然PEI未降低6周死亡率,但它显著降低了24小时内(比值比[OR]:0.89,95%置信区间[CI]:0.82-0.97,P=0.008)和6周内(风险比[HR]:0.36,95%CI:0.14-0.90,P=0.029)的再出血风险。在多因素回归分析中,最大静脉曲张直径>1.5cm(OR:1.23,95%CI:1.09-1.37,P<0.001)是24小时内再出血的独立危险因素。肌酐(HR:1.01,95%CI:1.01-1.02,P<0.001)和国际标准化比值(HR:2.99,95%CI:1.99-4.65,P<0.001)是6周内再出血的独立危险因素。
内镜手术前PEI降低了内镜手术后24小时内及6周内的再出血发生率。然而,PEI未降低内镜手术后的6周死亡率,且可能增加住院时间。